Abstracts

Indoxyl sulfate (IS) and p-Cresyl sulfate (PCS) are uraemic toxins originating from the breakdown of tryptophan and tyrosine/phenylalanine…

Chronic kidney disease (CKD) is a significant risk factor for preeclampsia (PE).1 However, the features of PE in this cohort of patients…

In the last few years, the effectiveness and role of drugs of the sodium-glucose co-transporter inhibitor group, or the so-called…

Thalassemia is a group of haemoglobinopathies characterised by the decrease or lack of β or α globin chain production haemoglobin (Hb)…

The following highlights focus on several insightful and innovative abstracts at EuroPCR 2022, covering topics such as transcatheter aorti…

The following highlights spotlight several fascinating and timely abstracts presented at the 32nd ECCMID…

DIETITIANS could provide outpatient medical gastroenterology clinics for patients with irritable bowel syndrome (IBS). Evidence for this was presented on 3rd October 2021 at the virtual UEG Week by Christian Shaw, Sheffield Teaching Hospital NHS Foundation Trust, UK.

BARIATRIC surgery is a safe and long-term treatment for weight loss; however, the rapid weight loss it induces is a major risk factor for the formation of cholesterol gallstones. The causal link between weight-loss and gallstone formation is not fully understood, but an important factor is the consequential imbalance in biliary lipids. Cholecystectomy at the time of bariatric surgery is the current standard treatment for gallstones, the evidence for the use of ursodeoxycholic acid (UDCA) prophylaxis is still under debate. Research led by Sylke Haal, Amsterdam UMC, University of Amsterdam, the Netherlands, was conducted to provide evidence for whether UDCA reduces the occurrence of gallstone disease after bariatric surgery.